Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenesis via paracrine signaling is the process of new blood vessel formation stimulated by factors secreted from nearby cells. Key paracrine factors include VEGF, HGF, IGF-1, IL-8, IL-6, PDGF, and TGF-β1, which promote endothelial cell proliferation, migration, and vessel stabilization. Dysregulation of this process contributes to diseases like cancer and ischemic disease, making it a therapeutic target for both inhibiting excessive angiogenesis and promoting it for tissue repair.
Paracrine signaling involves the secretion of soluble proteins or vesicles by source cells, diffusion through the local microenvironment, binding to specific receptors on target/endothelial cells, and activation of intracellular pathways leading to endothelial cell proliferation, migration, tube formation/capillary network assembly, and vessel maturation/stabilization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis via Paracrine Signaling.